Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Edgewise Therapeutics, Inc. (EWTX) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-49.01M |
|
-- |
|
-- |
|
$54.12M |
|
$-54.12M |
|
$5.10M |
|
$-49.01M |
|
$-49.01M |
|
$-49.01M |
|
$-49.01M |
|
$-49.01M |
|
$-49.01M |
|
$-54.12M |
|
$-54.54M |
|
107.12M |
|
107.12M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$509.79M |
|
$7.40M |
|
$8.73M |
|
$518.52M |
|
$22.54M |
|
-- |
|
$2.78M |
|
$25.32M |
|
$493.20M |
|
$493.20M |
|
$493.20M |
|
107.48M |
|
| Cash Flow Statement Financials | |
$-42.54M |
|
$2.43M |
|
$12.17M |
|
$61.15M |
|
$33.21M |
|
$-27.94M |
|
$8.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.61 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-42.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.94% |
|
-9.94% |
|
-9.45% |
|
-9.94% |
|
$4.59 |
|
$-0.40 |
|
$-0.40 |
|